CLINICAL_TRIALS
trial_result
· 2011-08-19
Clinical Trial Update: 12-week Efficacy of Indacaterol [Phase 3]
Summary
Novartis completed a Phase 3 trial assessing the 12-week efficacy of indacaterol in chronic obstructive pulmonary disease, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED | Results posted: 2011-08-19